Downregulation of SIRT2 has both negative effects, by increasing oxidative stress and necrosis [472], and positive effects, by protecting from ischemic injury [474] and inhibiting progression of Huntington’s and Parkinson’s diseases [475,477]. This evidence concerns the gene SIRT2 and Parkinson disease.